Elevated Levels of Hemoglobin A1c Are Associated With Cerebral White Matter Disease in Patients With Stroke [Clinical Sciences]
Conclusions—
Among known risk factors, higher levels of HbA1c were associated with cerebral WMD in stroke patients. This may suggest that chronic disturbance of glycemia measured by HbA1c plays a role in the pathophysiology of WMD.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00715533.
Source: Stroke - Category: Neurology Authors: Rozanski, M., Richter, T. B., Grittner, U., Endres, M., Fiebach, J. B., Jungehulsing, G. J. Tags: Cerebrovascular disease/stroke, Glucose intolerance, CT and MRI Clinical Sciences Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Hypertension | Ischemic Stroke | Laboratory Medicine | Neurology | Stroke | Study | Women